NYSE:AME - AMETEK Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $127.00
  • Forecasted Upside: -5.04 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$133.74
▲ +0.65 (0.49%)
1 month | 3 months | 12 months
Get New AMETEK Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AME and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AME

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$127.00
▼ -5.04% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for AMETEK in the last 3 months. The average price target is $127.00, with a high forecast of $160.00 and a low forecast of $84.00. The average price target represents a -5.04% upside from the last price of $133.74.
Buy
The current consensus among 8 polled investment analysts is to buy stock in AMETEK. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/29/2019
  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/27/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/23/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/21/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/22/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/20/2021Wells Fargo & CompanyBoost Price TargetPositive ➝ Overweight$140.00 ➝ $160.00Low
i
4/19/2021Morgan StanleyBoost Price TargetOverweight$133.00 ➝ $135.00Low
i
4/19/2021KeyCorpBoost Price TargetOverweight$140.00 ➝ $141.00N/A
i
4/13/2021KeyCorpBoost Price TargetOverweight$140.00 ➝ $141.00Low
i
4/12/2021Morgan StanleyBoost Price TargetOverweight$133.00 ➝ $135.00Low
i
4/1/2021KeyCorpBoost Price TargetOverweight$131.00 ➝ $140.00Low
i
3/30/2021Rosenblatt SecuritiesBoost Price TargetBuy$140.00 ➝ $142.00Low
i
3/15/2021KeyCorpBoost Price TargetOverweight$130.00 ➝ $131.00N/A
i
3/9/2021KeyCorpBoost Price TargetOverweight$130.00 ➝ $131.00High
i
2/9/2021DA DavidsonReiterated RatingBuyLow
i
Rating by M. Summerville at DA Davidson
2/5/2021Morgan StanleyBoost Price TargetOverweight$131.00 ➝ $133.00Low
i
11/23/2020Morgan StanleyBoost Price TargetOverweight$117.00 ➝ $131.00Low
i
11/13/2020KeyCorpBoost Price TargetPositive ➝ Overweight$118.00 ➝ $130.00Low
i
10/30/2020Rosenblatt SecuritiesBoost Price TargetBuy$125.00 ➝ $128.00Low
i
Rating by Scott Graham at Rosenblatt Securities
10/30/2020Morgan StanleyBoost Price TargetOverweight$112.00 ➝ $117.00Low
i
10/14/2020KeyCorpBoost Price TargetOverweight$112.00 ➝ $118.00Medium
i
10/13/2020Morgan StanleyBoost Price TargetOverweight$105.00 ➝ $112.00Low
i
8/7/2020Morgan StanleyBoost Price TargetOverweight$98.00 ➝ $105.00Low
i
8/5/2020Wells Fargo & CompanyBoost Price TargetOverweight$110.00 ➝ $115.00Medium
i
8/5/2020KeyCorpBoost Price TargetOverweight$100.00 ➝ $112.00Medium
i
8/4/2020Wells Fargo & CompanyReiterated RatingBuyMedium
i
7/14/2020Morgan StanleyBoost Price TargetOverweight$90.00 ➝ $98.00High
i
6/18/2020Rosenblatt SecuritiesBoost Price TargetBuy$92.00 ➝ $104.00Low
i
Rating by Scott Graham at Rosenblatt Securities
6/11/2020OppenheimerDowngradeOutperform ➝ Market PerformMedium
i
5/26/2020Bank of AmericaUpgradeNeutral ➝ Buy$100.00Medium
i
5/6/2020Robert W. BairdBoost Price TargetNeutral$80.00 ➝ $84.00Low
i
5/6/2020Wells Fargo & CompanyBoost Price TargetOverweight$90.00 ➝ $100.00Low
i
5/6/2020Morgan StanleyBoost Price TargetOverweight$82.00 ➝ $90.00Low
i
5/6/2020Rosenblatt SecuritiesInitiated CoverageBuy$92.00Low
i
Rating by Scott Graham at Rosenblatt Securities
4/19/2020Royal Bank of CanadaReiterated RatingBuyHigh
i
4/16/2020DA DavidsonReiterated RatingBuy$93.00High
i
Rating by Matt Summerville at DA Davidson
4/15/2020Morgan StanleyBoost Price TargetOverweight$75.00 ➝ $82.00Medium
i
Rating by Joshua Pokrzywinski at Morgan Stanley
4/6/2020Rosenblatt SecuritiesReiterated RatingBuy$90.00High
i
Rating by Scott Graham at Rosenblatt Securities
4/3/2020DA DavidsonLower Price Target$115.00 ➝ $95.00Medium
i
3/30/2020KeyCorpLower Price TargetOverweight$110.00 ➝ $100.00Medium
i
3/17/2020Morgan StanleyLower Price TargetOverweight$107.00 ➝ $78.00Low
i
Rating by Joshua Pokrzywinski at Morgan Stanley
3/16/2020Wells Fargo & CompanyLower Price TargetOverweight$120.00 ➝ $95.00High
i
3/12/2020CowenUpgradeMarket Perform ➝ Outperform$100.00 ➝ $95.00High
i
2/10/2020Langenberg & CompanyDowngradeHold$100.00Medium
i
Rating by Brian Langenberg at Langenberg & Company
2/7/2020StephensBoost Price TargetOverweight$113.00 ➝ $115.00High
i
2/6/2020Robert W. BairdBoost Price TargetNeutral$96.00 ➝ $98.00Medium
i
1/31/2020Rosenblatt SecuritiesReiterated RatingBuy$114.00Low
i
Rating by Scott Graham at Rosenblatt Securities
1/16/2020Robert W. BairdDowngradeOutperform ➝ Neutral$96.00Low
i
1/14/2020Morgan StanleyLower Price TargetOverweight$109.00 ➝ $107.00Low
i
Rating by Joshua Pokrzywinski at Morgan Stanley
1/13/2020CowenDowngradeOutperform ➝ Market PerformLow
i
1/9/2020Wolfe ResearchDowngradeOutperform ➝ Peer PerformLow
i
Rating by Nigel Coe at Wolfe Research
1/2/2020Rosenblatt SecuritiesReiterated RatingBuy$115.00Low
i
12/11/2019Morgan StanleyBoost Price TargetOverweight$102.00 ➝ $109.00Medium
i
Rating by Joshua Pokrzywinski at Morgan Stanley
11/27/2019Gordon HaskettInitiated CoverageBuy$125.00Low
i
11/19/2019KeyCorpBoost Price TargetOverweight$100.00 ➝ $110.00High
i
11/19/2019Gordon HaskettInitiated CoverageBuy$125.00High
i
11/7/2019Rosenblatt SecuritiesInitiated CoverageBuy$115.00Low
i
11/1/2019Wolfe ResearchSet Price TargetBuy$100.00Medium
i
Rating by Nigel Coe at Wolfe Research
11/1/2019Morgan StanleySet Price TargetBuy$97.00 ➝ $102.00Low
i
Rating by Joshua Pokrzywinski at Morgan Stanley
10/11/2019Bank of AmericaDowngradeBuy ➝ Neutral$105.00 ➝ $95.00Low
i
Rating by Andrew Obin at Bank of America Co.
9/30/2019Bank of AmericaSet Price TargetBuy$105.00High
i
7/31/2019Royal Bank of CanadaSet Price TargetBuy$95.00Medium
i
Rating by Deane Dray at Royal Bank of Canada
7/31/2019OppenheimerBoost Price TargetOutperform$94.00 ➝ $100.00Medium
i
7/31/2019KeyCorpBoost Price Target$94.00 ➝ $100.00Medium
i
7/31/2019Morgan StanleyBoost Price TargetOverweight$95.00 ➝ $97.00Medium
i
Rating by Joshua Pokrzywinski at Morgan Stanley
5/15/2019Berenberg BankInitiated CoverageBuy ➝ Buy$100.00Low
i
5/3/2019Morgan StanleySet Price TargetBuy$95.00Low
i
Rating by Joshua Pokrzywinski at Morgan Stanley
5/3/2019Vertical ResearchReiterated RatingBuyLow
i
Rating by Jeffrey Sprague at Vertical Research
5/2/2019BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$99.00 ➝ $101.00Low
i
5/2/2019DA DavidsonBoost Price TargetBuy$101.00Low
i
5/2/2019KeyCorpBoost Price TargetOverweight ➝ Overweight$86.00 ➝ $94.00Low
i
3/15/2019DA DavidsonBoost Price TargetBuy$92.00Low
i
1/29/2019BMO Capital MarketsReiterated RatingBuy$90.00Low
i
1/8/2019Wolfe ResearchUpgradeMarket Perform ➝ OutperformLow
i
1/6/2019StephensReiterated RatingBuy$79.00Low
i
12/19/2018Royal Bank of CanadaReiterated RatingBuy$82.00High
i
12/18/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight$81.00 ➝ $85.00Medium
i
12/12/2018CowenReiterated RatingBuy$91.00High
i
11/19/2018StephensInitiated CoverageOverweight$87.00Medium
i
11/5/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$84.00 ➝ $81.00Medium
i
11/2/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$82.00 ➝ $84.00N/A
i
11/2/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$93.00 ➝ $91.00N/A
i
8/12/2018CowenReiterated RatingBuy$85.00Low
i
8/1/2018OppenheimerBoost Price TargetOutperform$85.00 ➝ $90.00Low
i
8/1/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$87.00 ➝ $91.00Low
i
8/1/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$92.00 ➝ $93.00Low
i
8/1/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$79.00 ➝ $84.00Medium
i
8/1/2018Royal Bank of CanadaReiterated RatingBuy$86.00Medium
i
5/3/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$76.00 ➝ $79.00Low
i
5/3/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$90.00 ➝ $92.00Low
i
4/12/2018DA DavidsonInitiated CoverageBuy$85.00Medium
i
Rating by Matt Summerville at DA Davidson
2/7/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Overweight$67.00 ➝ $76.00Low
i
2/2/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$88.00 ➝ $90.00Low
i
2/2/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$82.00 ➝ $86.00Medium
i
2/1/2018Stifel NicolausReiterated RatingBuy$92.00Low
i
Rating by Mark Davies Jones at Stifel Nicolaus
1/26/2018BMO Capital MarketsReiterated RatingBuy$88.00Medium
i
1/19/2018KeyCorpReiterated RatingBuy$82.00Medium
i
1/18/2018Wells Fargo & CompanySet Price TargetBuy$80.00 ➝ $88.00Medium
i
12/22/2017CowenReiterated RatingBuy$80.00N/A
i
12/21/2017OppenheimerReiterated RatingBuy$75.00Low
i
12/11/2017BMO Capital MarketsReiterated RatingBuy$80.00Low
i
12/11/2017Stifel NicolausReiterated RatingBuyLow
i
Rating by Mark Davies Jones at Stifel Nicolaus
11/3/2017OppenheimerBoost Price TargetOutperform$75.00N/A
i
11/3/2017BMO Capital MarketsBoost Price TargetOutperform$77.00 ➝ $78.00N/A
i
11/3/2017Morgan StanleyBoost Price TargetEqual Weight$64.00 ➝ $67.00N/A
i
11/3/2017Robert W. BairdBoost Price TargetOutperform$70.00 ➝ $77.00N/A
i
10/13/2017Jefferies Financial GroupBoost Price TargetBuy$66.00 ➝ $77.00N/A
i
10/13/2017Royal Bank of CanadaReiterated RatingBuy$70.00N/A
i
10/6/2017Robert W. BairdReiterated RatingBuy$70.00N/A
i
10/6/2017Stifel NicolausSet Price TargetBuy$70.00N/A
i
Rating by Mark Davies Jones at Stifel Nicolaus
8/3/2017BMO Capital MarketsBoost Price TargetOutperform$67.00 ➝ $69.00Low
i
8/3/2017OppenheimerBoost Price TargetOutperform$65.00 ➝ $70.00Low
i
8/3/2017Jefferies Financial GroupReiterated RatingBuy$66.00Low
i
7/7/2017CowenReiterated RatingOutperform$62.00 ➝ $66.00Low
i
6/27/2017BMO Capital MarketsReiterated RatingBuy$67.00Low
i
6/8/2017Stifel NicolausReiterated RatingBuy ➝ Buy$66.00 ➝ $69.00Low
i
6/6/2017Royal Bank of CanadaReiterated RatingBuy$67.00Low
i
5/8/2017Morgan StanleyBoost Price TargetEqual Weight$57.00 ➝ $62.00Low
i
5/3/2017BMO Capital MarketsReiterated RatingOutperform$65.00 ➝ $67.00Low
i
5/3/2017Jefferies Financial GroupReiterated RatingBuy$63.00 ➝ $66.00Low
i
3/27/2017BMO Capital MarketsReiterated RatingBuy$65.00Low
i
2/15/2017Atlantic SecuritiesUpgradeNeutral ➝ Overweight$48.00 ➝ $62.00N/A
i
2/8/2017Royal Bank of CanadaReiterated RatingBuy$57.00 ➝ $60.00N/A
i
Rating by Deane Dray at Royal Bank of Canada
2/8/2017Royal Bank of CanadaBoost Price TargetOutperform$57.00 ➝ $60.00N/A
i
1/4/2017Royal Bank of CanadaSet Price TargetBuy$57.00N/A
i
Rating by Deane Dray at Royal Bank of Canada
1/4/2017CowenUpgradeMarket Perform ➝ OutperformN/A
i
12/22/2016Robert W. BairdUpgradeNeutral ➝ Outperform$47.00 ➝ $57.00N/A
i
11/2/2016Royal Bank of CanadaLower Price TargetOutperform$59.00 ➝ $57.00N/A
i
11/2/2016Stifel NicolausLower Price TargetBuy$53.00 ➝ $50.00N/A
i
11/2/2016Royal Bank of CanadaReiterated RatingOutperform$59.00 ➝ $57.00N/A
i
10/24/2016Janney Montgomery ScottInitiated CoverageBuy$56.00N/A
i
8/9/2016Jefferies Financial GroupLower Price TargetBuy$56.00 ➝ $54.00N/A
i
Rating by Bhupender Bohra at Jefferies Financial Group Inc.
8/5/2016Royal Bank of CanadaReiterated RatingOutperform$56.00 ➝ $53.00N/A
i
8/5/2016Stifel NicolausLower Price TargetBuy$56.00 ➝ $50.00N/A
i
8/5/2016OppenheimerLower Price TargetOutperform$56.00 ➝ $54.00N/A
i
Rating by Christopher Glynn at Oppenheimer Holdings Inc.
8/5/2016BMO Capital MarketsSet Price TargetBuy$53.00N/A
i
Rating by Scott Graham at BMO Capital Markets
8/5/2016Royal Bank of CanadaLower Price TargetOutperform$56.00 ➝ $53.00N/A
i
6/9/2016OppenheimerReiterated RatingOutperform$56.00N/A
i
Rating by Christopher Glynn at Oppenheimer Holdings Inc.
4/30/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Bhupender Bohra at Jefferies Financial Group Inc.
4/29/2016Atlantic SecuritiesDowngradeOverweight ➝ Neutral$51.00N/A
i
4/29/2016Robert W. BairdDowngradeOutperform ➝ Neutral$49.00 ➝ $51.00N/A
i
(Data available from 4/22/2016 forward)
AMETEK logo
AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices worldwide. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets. This segment also provides power quality monitoring and metering devices, uninterruptible power supplies, programmable power equipment, electromagnetic compatibility test equipment, sensors for gas turbines, dashboard instruments for heavy trucks and other vehicles, and instrumentation and controls for the food and beverage industries; and aircraft and engine sensors, monitoring systems, power supplies, fuel and fluid measurement systems, and data acquisition units for the aerospace industry. Its EMG segment offers engineered electrical connectors and electronics packaging for protecting sensitive electronic devices; precision motion control products for data storage, medical devices, business equipment, automation and other applications; high-purity powdered metals, strip and foil, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for use in thermal management, military, commercial aircraft, and military ground vehicles; and motors for use in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps, and industrial blowers. This segment also operates a network of aviation maintenance, repair, and overhaul facilities. In addition, the company offers clinical and education communication solutions for healthcare facilities and educational institutions. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.
Read More

Today's Range

Now: $133.74
$132.96
$133.74

50 Day Range

MA: $126.22
$120.39
$133.15

52 Week Range

Now: $133.74
$74.01
$134.80

Volume

3,577 shs

Average Volume

1,022,293 shs

Market Capitalization

$30.87 billion

P/E Ratio

35.38

Dividend Yield

0.61%

Beta

1.36

Frequently Asked Questions

What sell-side analysts currently cover shares of AMETEK?

The following sell-side analysts have issued research reports on AMETEK in the last twelve months: Bank of America Co., DA Davidson, KeyCorp, Morgan Stanley, Oppenheimer Holdings Inc., Robert W. Baird, Rosenblatt Securities, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for AME.

What is the current price target for AMETEK?

6 Wall Street analysts have set twelve-month price targets for AMETEK in the last year. Their average twelve-month price target is $127.00, suggesting a possible downside of 4.6%. Wells Fargo & Company has the highest price target set, predicting AME will reach $160.00 in the next twelve months. Robert W. Baird has the lowest price target set, forecasting a price of $84.00 for AMETEK in the next year.
View the latest price targets for AME.

What is the current consensus analyst rating for AMETEK?

AMETEK currently has 2 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AME will outperform the market and that investors should add to their positions of AMETEK.
View the latest ratings for AME.

What other companies compete with AMETEK?

How do I contact AMETEK's investor relations team?

AMETEK's physical mailing address is 1100 CASSATT ROAD, BERWYN PA, 19312. The technology company's listed phone number is 610-647-2121. The official website for AMETEK is www.ametek.com.